1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Issue 10212 (23rd November 2019) Authors: Burtness, Barbara; Harrington, Kevin J; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro, Gilberto; Psyrri, Amanda; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G M; Mesía, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Wan Ishak, Wan Zamaniah; Hon... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Issue 10212 (23rd November 2019) Authors: Burtness, Barbara; Harrington, Kevin J; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro, Gilberto; Psyrri, Amanda; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G M; Mesía, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Wan Ishak, Wan Zamaniah; Hon... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. (14th May 2020) Authors: Harrington, Kevin J; Soulières, Denis; Le Tourneau, Christophe; Dinis, Jose; Licitra, Lisa F; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal H; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Ellison, Misoo C; Cheng, Jonathan D; Chirovsky, Diana Romana; Swaby, Ramona F; Cohen, Ezra E W Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 2(2021) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Issue 7 (July 2016) Authors: Seiwert, Tanguy Y; Burtness, Barbara; Mehra, Ranee; Weiss, Jared; Berger, Raanan; Eder, Joseph Paul; Heath, Karl; McClanahan, Terrill; Lunceford, Jared; Gause, Christine; Cheng, Jonathan D; Chow, Laura Q Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗